Device Cardiothoracic

Minirumel

Payments companies reported to CMS as associated with Minirumel. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$139Kassociated payments (2023-2025)
28clinicians with associated payments
1company reporting

By year

2025 $139K

Payments reported as associated with Minirumel, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $136K
Surgical $2,589
Family $81.65
Physician Assistant $14.19
Vascular Surgery $14.19

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Minirumel

These are the largest totals companies reported as associated with Minirumel. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Defrain Pensacola, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $64,757.00
Mahesh Ramchandani Houston, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $27,567.21
Mario Castillo-Sang Edgewood, KY Thoracic Surgery (Cardiothoracic Vascular Surgery) $20,275.44
Juan Penaranda-Canal Edgewood, KY Thoracic Surgery (Cardiothoracic Vascular Surgery) $14,106.41
Ziyab Sarfaraz Houston, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,968.93
Gianluca Torregrossa Chicago, IL Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,489.18
Amanda Yakobitis Wynnewood, PA Surgical $2,460.62
Paul Digiorgi Port Charlotte, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $505.94
Husam Balkhy Chicago, IL Thoracic Surgery (Cardiothoracic Vascular Surgery) $224.19
Richard Amato Pensacola, FL Surgical $71.35

Prescribed Minirumel?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.